Literature DB >> 4046756

Tru-cut and Menghini needles: different yield in the histological diagnosis of liver disease.

L Vargas-Tank, V Martínez, M I Jirón, J R Soto, R Armas-Merino.   

Abstract

An evaluation of the information obtained by percutaneous liver biopsy performed with Travenol Tru-cut ("Tru-cut"), Menghini's 1.9 and 1.6 needles, was done using cadavers. All needles used had a similar, low number of "failures". Recognition of diffuse liver lesions, excluding fibrosis, was very high regardless of the needle used. Identification of cirrhosis was significantly more frequent in biopsies performed with the Tru-cut needle.

Entities:  

Mesh:

Year:  1985        PMID: 4046756     DOI: 10.1111/j.1600-0676.1985.tb00234.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  Clinical Utility of Biomarkers of Liver Fibrosis.

Authors:  Keyur Patel; Don C Rockey
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

Review 2.  Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Authors:  Giada Sebastiani; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.

Authors:  I T Gilmore; A Burroughs; I M Murray-Lyon; R Williams; D Jenkins; A Hopkins
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.